John Neis

John Neis is a Managing Director and heads the firm’s Healthcare practice. He has over 23 years in the venture capital industry, which have enabled him to experience several industry cycles, and to serve on the Board of Directors of companies from formation through IPO or sale.

John currently serves on the Boards of Directors of Virent Energy Systems, Deltanoid Pharmaceuticals and Cellectar. He is a former member of the Boards of Directors of several firms including TomoTherapy (NASDAQ:TOMO), Third Wave Technologies (NASDAQ:TWTI – acquired by Hologic) and NimbleGen Systems (acquired by Roche).

John was appointed by the Governor to the Board of the Wisconsin Technology Council, which is the science and technology advisor to the Governor and Legislature. He also serves on the advisory boards for the Weinert Applied Ventures Program, the University of Wisconsin-Madison Business School and Tandem Press. He is a member of the patent advisory group of the National Venture Capital Association. His achievements were recognized when he was named to the 2008 Midas List, Forbes annual listing of the top 100 tech dealmakers in the world.

John graduated Magna Cum Laude with a B.S. in Finance from the University of Utah, and received a M.S. in Marketing and Finance from the University of Wisconsin–Madison. He is a Chartered Financial Analyst.